Fulcrum Therapeutics (FULC) Stock: Buy, Sell, or Hold?
FULC - Fulcrum Therapeutics, Inc. Common Stock
$3.67
0.00 (0.00%)
▲
5d:
-2.13%
30d:
-3.17%
90d:
+0.55%
WAIT
LOW Confidence
Analysis Updated: Oct 15, 2026 12:00 AM ET
Earnings: Nov 04, 2026
18d
Get Alerted When FULC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: FULC shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: FULC shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: FULC is currently trading at $3.67, which is considered oversold relative to its 30-day fair value range of $3.70 to $3.80.
Technical Outlook: Technically, FULC is showing sideways momentum. The price is currently testing key support at $3.65. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 51/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, FULC is showing sideways momentum. The price is currently testing key support at $3.65. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 51/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.70 -
$3.80
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Protect Your Profits
Holding FULC? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (51/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($3.67)
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.70 -
$3.80
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.65
Resistance Level
$3.79
Current Trend
Sideways
Technical data as of
Oct 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.70
Wall Street Target
$3.67
(-0.1%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: October 16, 2026 7:31 AM ET
Data refreshes hourly during market hours. Next update: 8:31 AM
Data refreshes hourly during market hours. Next update: 8:31 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FULC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
27 analysts |
$92 | 66 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$285 | 58 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
22 analysts |
$109 | 65 BUY |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$129 | 72 BUY |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
17 analysts |
$37 | 68 BUY |
Advanced FULC Option Strategies
Professional options setups generated by AI based on today's FULC price and gamma walls.
